| Name | MAX-40279 hemiadipate |
|---|
| Description | MAX-40279 hemiadipate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemiadipate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
|---|---|
| Related Catalog | |
| Target |
FLT3 and FGFR[1] |
| References |
[1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
| Molecular Formula | C28H33FN6O5S |
|---|---|
| Molecular Weight | 584.66 |